Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Ikusi/ Ireki
Data
2018-04-19Egilea
Turajlic, Samra
Xu, Hang
Litchfield, Kevin
Rowan, Andrew
Chambers, Tim
Nicol, David
O'Brien, Tim
Larkin, James
Horswell, Stuart
Stares, Mark
Au, Lewis
Jamal-Hanjani, Mariam
Challacombe, Ben
Chandra, Ashish
Hazell, Steve
Eichler-Jonsson, Claudia
Soultati, Aspasia
Chowdhury, Simon
Rudman, Sarah
Lynch, Joanna
Archana Sinduri, Fernando
Stamp, Gordon
Nye, Emma
Jabbar, Faiz
Spain, Lavinia
Lall, Sharanpreet
Guarch, Rosa
Falzon, Mary
Proctor, Ian
Pickering, Lisa
Gore, Martin E.
Watkins, Thomas B. K.
Ward, Sophia
Stewart, Aengus
DiNatale, Renzo
Becerra, Maria F.
Reznik, Ed
Hsieh, James J.
Richmond, Todd A.
Mayhew, George F.
Hill, Samantha M.
McNally, Catherine D.
Jones, Carol
Rosenbaum, Heidi
Stanislaw, Stacey
Burgess, Daniel L.
Alexander, Nelson R.
Swanton, Charles
Cell 173(3) : 581-594 (2018)
Laburpena
Clear-cell renal cell carcinoma (ccRCC) exhibits a broad range of metastatic phenotypes that have not been systematically studied to date. Here, we analyzed 575 primary and 335 metastatic biopsies across 100 patients with metastatic ccRCC, including two cases sampledat post-mortem. Metastatic competence was afforded by chromosome complexity, and we identify 9p loss as a highly selected event driving metastasis and ccRCC-related mortality (p = 0.0014). Distinct patterns of metastatic dissemination were observed, including rapid progression to multiple tissue sites seeded by primary tumors of monoclonal structure. By contrast, we observed attenuated progression in cases characterized by high primary tumor heterogeneity, with metastatic competence acquired gradually and initial progression to solitary metastasis. Finally, we observed early divergence of primitive ancestral clones and protracted latency of up to two decades as a feature of pancreatic metastases.